Overall survival demonstrated early in Checkmate-078
The phase III study CheckMate -078, evaluating nivolumab versus docetaxel in previously treated advanced or metastatic…
The phase III study CheckMate -078, evaluating nivolumab versus docetaxel in previously treated advanced or metastatic…
University of Colorado Cancer Center researchers presented the results of a phase II clinical trial…
A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients…
New data from parts 1 and 2 of the ongoing ARIEL2 phase II trial was presented…
A personalised cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukaemia (AML),…
A phase clinical trial evaluating the efficacy and safety of nivolumab (marketed as Opdivo by Bristol…
Preoperative high-intensity interval training (HIIT) in patients with resectable non-small cell lung cancer (NSCLC) improved…
Patients whose acute myelogenous leukaemia (AML) had relapsed or was resistant to chemotherapy and those…
In the era of precision medicine, targeting the mutations driving cancer growth, rather than the…
Researchers reported encouraging early results from a phase II trial that matches patients with molecular…